ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'
Although myocardial ischaemia usually manifests as a consequence of atherosclerosis-
dependent obstructive epicardial coronary artery disease, a significant percentage of …
dependent obstructive epicardial coronary artery disease, a significant percentage of …
Coronary microvascular obstruction: the new frontier in cardioprotection
G Heusch - Basic Research in Cardiology, 2019 - Springer
Cardioprotection aims at infarct size reduction and improvement of clinical outcome from
myocardial infarction. The translation of cardioprotection from preclinical and promising …
myocardial infarction. The translation of cardioprotection from preclinical and promising …
Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve …
Primary percutaneous coronary intervention is nowadays the preferred reperfusion strategy
for patients with acute ST-segment–elevation myocardial infarction, aiming at restoring …
for patients with acute ST-segment–elevation myocardial infarction, aiming at restoring …
Myocardial no-reflow in humans
In a variable proportion of patients presenting with ST-segment elevation myocardial
infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves …
infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves …
[HTML][HTML] The no-reflow phenomenon: state of the art
C Bouleti, N Mewton, S Germain - Archives of cardiovascular diseases, 2015 - Elsevier
Primary percutaneous coronary intervention (PCI) is the best available reperfusion strategy
for acute ST-segment elevation myocardial infarction (STEMI), with nearly 95% of occluded …
for acute ST-segment elevation myocardial infarction (STEMI), with nearly 95% of occluded …
Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction
K Iwakura, H Ito, M Ikushima, S Kawano… - Journal of the American …, 2003 - jacc.org
Objectives: We investigated the association between hyperglycemia and the no-reflow
phenomenon in patients with acute myocardial infarction (AMI). Background: Hyperglycemia …
phenomenon in patients with acute myocardial infarction (AMI). Background: Hyperglycemia …
[HTML][HTML] The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis
Objective To investigate the no reflow risk factors after percutaneous coronary intervention in
ST elevation myocardial infarction patients. Method Sample size, mean±standard deviation …
ST elevation myocardial infarction patients. Method Sample size, mean±standard deviation …
No-reflow phenomenon and prognosis in patients with acute myocardial infarction
H Ito - Nature clinical practice Cardiovascular medicine, 2006 - nature.com
The rapid restoration of coronary flow to the jeopardized myocardium has become an
essential part of therapy after acute myocardial infarction. Despite an open infarct-related …
essential part of therapy after acute myocardial infarction. Despite an open infarct-related …
Novel insights into an “old” phenomenon: the no reflow
Coronary artery diseases and particularly acute myocardial infarction are the leading causes
of mortality and morbidity in western countries. Despite the achievements of the last decades …
of mortality and morbidity in western countries. Despite the achievements of the last decades …
Pathophysiology, diagnosis, and management of the no-reflow phenomenon
Successful reperfusion of an infarct-related coronary artery by primary percutaneous
intervention or fibrinolysis during acute ST-elevation myocardial infarction (STEMI) does not …
intervention or fibrinolysis during acute ST-elevation myocardial infarction (STEMI) does not …